| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |